[Fwd: VITAMIN B12 INJECTIONS & ELEVATED COBALT LEVELS]

[Guest guest]

--- [CoMeD] [PR] VITAMIN B12 INJECTIONS & ELEVATED COBALT LEVELS

Date: Sat, 01 May 2010 22:22:30 -0400

To: paulgkingphd@...

All,

Attached is CoMeD Press Release titled, " VITAMIN B12

INJECTIONS & ELEVATED COBALT LEVELS " , which explores

the effect of injecting methylcobalimin (the methyl

form of vitamin B12) on the level of cobalt in blood

and urine, and reports that the levels found appeared

to reach toxic levels in some instances.

Both a " .pdf " and a " .doc " file are provided.

For those who do not get attachments, the text of this

Press Release is roughly:

>

> VITAMIN B12 INJECTIONS & ELEVATED COBALT LEVELS

>

>PRESS RELEASE CONTACTS:

>For Immediate Release CoMeD President [Rev. K.

>May 1, 2010 Sykes (Richmond, VA) ]

> CoMeD Sci. Advisor [Dr.

> G. King (Lake Hiawatha, NJ)

> ]

>

>WASHINGTON, DC - A new study, " An Autism Cohort

>Study of Cobalt Levels Following Vitamin B12

>Injections " , published in the most recent issue

>of the peer-reviewed Toxicological & Environmental

>Chemistry [1], confirms a significant association

> between the frequency of methylcobalamin (vitamin

>B12) injections and blood/urinary cobalt levels in

>subjects diagnosed with an autism spectrum disorder

>as well as a significant association between cobalt

>exposure and damage to human neurons.

> [1] Geier DA, Geier MR An Autism Cohort Study of

> Cobalt Levels Following Vitamin B12 Injections.

> Toxicological & Environmental Chemistry 2010;

> 92: 1025-1037.

>

>It was previously suggested by investigators that

>methylcobalamin (the methyl form of vitamin B12

>[methyl B12]) injections may play an important role

>in the treatment of subjects diagnosed with an

>autism spectrum disorder. It was determined that

>the typical dosage of injected methyl B12 (75 µg/kg

>bodyweight) utilized in subjects diagnosed with an

>autism spectrum disorder results in an instantaneous

>exposure to cobalt equal to about 25% of the entire

>normal body-burden of cobalt, and that this exposure

>is to be repeated every several days for an

>indefinite period of time. The aim of this new study

>was to evaluate the potential effects of methyl B12

>injections on cobalt levels in a cohort of subjects

>diagnosed with an autism spectrum disorder.

>

>The results of the study showed subjects diagnosed

>with an autism spectrum disorder receiving injected

>methyl B12 at least once every three days had

>significant increased average levels of cobalt in

>the blood (6.83-fold) and urine (51-fold) in

>comparison to subjects not receiving injected methyl

>B12. Further, the more frequently the methyl B12

>was injected, the higher the observed cobalt levels

>in the blood and urine were. Overall, the subjects

>receiving injected methyl B12 every second day had

>average blood and urinary cobalt levels in excess

>of the cobalt maximal occupational exposure limits.

>Finally, the study also found that inorganic cobalt

>was able to induce significant damage to human

>neurons in a dose-dependent manner.

>

>The present study is the first of its kind to eval-

>uate the potential distribution patterns of cobalt

>in the human body following injected methyl B12,

>as well as the potential toxic consequences of

>cobalt to human tissue culture cells. The investi-

>gators concluded, " Â… there may be significant

>potential benefits to the administration of methyl-

>cobalamin to subjects diagnosed with an ASD Â… " but,

> " Â… it is important that physicians prescribing

>methylcobalamin injections for subjects should

>routinely monitor blood and urine cobalt levels,

>and, to be safe, ensure that their dosing regimens

>do not result in blood and/or urine cobalt levels

>in excess of maximal exposure safety limits.

>These concerns and caveats are all important in

>light of the rapid expansion of the use of methyl-

>cobalamin injections in the treatment of a number

>of different conditions. "

>

>These investigators commented that sublingual

>preparations containing 50 µg of methyl B12 per

>dose administered to subjects diagnosed with an

>autism spectrum disorder on a daily basis were

>found to induce apparently adequate blood levels

>of vitamin B12 in the recipients even though

>their blood/urine levels were usually below the

>limits of detection in the lab testing of their

>blood/urine samples.

>

>This landmark study was supported by the not-

>for-profit 501© 3 corporations: CoMeD, Inc

>and the Institute of Chronic Illnesses, Inc.

>

>Your generous tax-free donations will help us

>to fund additional research, similar to the

>present study.

>

____________________________________________________

____________________________________________________

To support the ongoing efforts of CoMeD, Inc. with

your tax-deductible contributions, please use the

PayPal link on CoMeD's Internet website,

http://www.Mercury-freeDrugs.org.

CoMeD, Inc. is a not-for-profit 501©(3) corpora-

tion that is actively engaged in legal, educational

and scientific efforts to stop all use of mercury

in medicine, and to ban the use of all mercury-

containing medicines.

Please do send this to all of your relatives and

friends, who may be using injected methylcobalimin

[methyl B12] to treat their children or themselves

for an apparent vitamin B12 deficiency.

Hopefully, after a careful reading of the text, all

will KNOW more about the use of methyl B12 and the

potential for the level of Cobalt in the blood and

urine of those who are receiving methyl B12 injec-

tions to exceed the Cobalt levels where there MAY

be a toxicity concern.

Respectfully,

G. King, PhD

http://www.dr-king.com

CoMeD Science Advisor

++++++++++++++++++++++++++++++++++++++++++++++++++++++++

____________________________________________________________

Send any screenshot to your friends in seconds...

Works in all emails, instant messengers, blogs, forums and social networks.

TRY IM TOOLPACK at http://www.imtoolpack.com/default.aspx?rc=if2 for FREE

2 of 2 File(s)

20100501_CoMeD_PR_VitB12Injection&ElevatedCobaltLevels_b.pdf

20100501_CoMeD_PR_VitB12Injection&ElevatedCobaltLevels_final.doc